Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine
Clinical trial NCT00289796 · COMPLETED
Trial details
- NCT number
- NCT00289796
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2006-04-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.